Anti-Endoglin / CD105 (Angiogenesis Marker) Monoclonal Antibody(Clone: ENG/3269), Clone: [ENG/3269], Mouse

Catalog Number: ABI-36-2214
Article Name: Anti-Endoglin / CD105 (Angiogenesis Marker) Monoclonal Antibody(Clone: ENG/3269), Clone: [ENG/3269], Mouse
Biozol Catalog Number: ABI-36-2214
Supplier Catalog Number: 36-2214
Alternative Catalog Number: ABI-36-2214-100UG
Manufacturer: Abeomics
Host: Mouse
Category: Antikörper
Application: IHC
Species Reactivity: Human
Immunogen: Recombinant human Endoglin protein fragment (aa74-251) (exact sequence is proprietary)
Alternative Names: CD105, END, Endoglin, Eng, HHT1, S-endoglin
CD105/Endoglin is a Type I membrane glycoprotein located on cell surfaces and is part of the TGF-alphabeta receptor complex. This protein has been found on endothelial cells, activated macrophages, fibroblasts, and smooth-muscle cells. Endoglin has a role in the development of the cardiovascular system and in vascular remodeling. Its expression is regulated during heart development. CD105 is highly expressed in endothelial cells during tumor angiogenesis and inflammation, with weak or negative expression in vascular endothelium of normal tissues. Angiogenesis is a promising prognostic marker in a variety of tumors. Endoglin is a more specific and sensitive marker for tumor angiogenesis than CD31 or CD34, as it labels only newly-formed blood vessels and may serve as a prognostic marker for Prostate Adenocarcinoma, and cancers of the lung, stomach, breast, and brain.
Clonality: Monoclonal
Clone Designation: [ENG/3269]
NCBI: 2022
UniProt: P17813
Application Dilute: Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95&degC followed by cooling at RT for 20 minutes),